Fairmount Funds Management LLC

Fairmount Funds Management LLC reported 12 holdings worth US$1.59B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Fairmount Funds Management LLC reported 12 holdings worth US$1.59B as of Sep 30, 2026. Largest: Oruka Therapeutics, Inc., Dianthus Therapeutics, Inc. and Cogent Biosciences, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
12
Value as reported
US$1.59B

The filing in full

CompanySharesValue as reported% of portfolio
Oruka Therapeutics, Inc.3.71MUS$309M19.4%
Dianthus Therapeutics, Inc.2.54MUS$223M14.0%
Cogent Biosciences, Inc.5.5MUS$176M11.1%
Viridian Therapeutics, Inc.5.09MUS$105M6.6%
Enliven Therapeutics, Inc.1.86MUS$85.1M5.3%
Jade Biosciences, Inc.4.55MUS$64M4.0%
Zenas BioPharma, Inc.2.37MUS$64M4.0%
Crescent Biopharma, Inc.3.6MUS$52.5M3.3%
Sensei Biotherapeutics, Inc.722KUS$21.5M1.3%
Inhibikase Therapeutics, Inc.8.63MUS$17.7M1.1%
Apogee Therapeutics, Inc.0US$00.00%
Damora Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related